{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "Forty-four patients with stage I to IIIA non-small cell lung cancer ( American Joint Committee on Cancer Staging Manual , seventh edition) were randomized"
      },
      "Participants": {
        "score": 2,
        "evidence": "Forty-four patients with stage I to IIIA non-small cell lung cancer ( American Joint Committee on Cancer Staging Manual , seventh edition)"
      },
      "Intervention": {
        "score": 2,
        "evidence": "randomized to nivolumab (N; 3 mg/kg intravenously on days 1, 15, and 29; n = 23) or nivolumab with ipilimumab (NI; I, 1 mg/kg intravenously on day 1; n = 21)"
      },
      "Objective": {
        "score": 1,
        "evidence": "We assessed perioperative outcomes of patients treated with Nivolumab or Nivolumab plus Ipilimumab (NEOSTAR)"
      },
      "Method_Outcome": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Blinding": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "Forty-four patients with stage I to IIIA non-small cell lung cancer"
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "In the N arm, 21 (91%) were resected on-trial, 1 underwent surgery off-trial, and one was not resected (toxicity-related). In the NI arm, 16 (76%) resections were performed on-trial, one off-trial, and 4 were not resected (none toxicity-related)."
      },
      "Result_Outcome": {
        "score": 1,
        "evidence": "All 37 achieved Ro resection."
      },
      "Harms": {
        "score": 1,
        "evidence": "Pulmonary, cardiac, enteric, neurologic, and wound complications occurred in 9 (24%), 4 (11%), 2 (5%), 1 (3%), and 1 (3%) patient, respectively."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 10,
    "max_score": 25
  },
  "model": "gpt-4o"
}